APPLICATIONS OF TECHNOLOGY: Cancer diagnostics and therapy ADVANTAGES: Fast, accurate, and affordable Improves tumor staging and patient stratification for most cancers ABSTRACT: Berkeley Lab researcher Heinz-Ulrich Weier has developed Genetic Barcodes, a fluorescent in situ hybridization (FISH)-based assay offering affordable diagnostics for the early … [Read more...] about Genetic Barcodes for Cancer Prediction and Prognosis IB-2897
Cancer Therapeutics
Increased Glucose Metabolism is Oncogenic; Its Reversal May Be Therapeutic IB-2921
APPLICATIONS OF TECHNOLOGY: Cancer diagnostics Cancer therapeutics Cancer research ADVANTAGES: Provides markers correlated with increased metastases risk Provides for therapies that block or reverse cancer progression through adjusting glucose metabolism ABSTRACT: Berkeley Lab researchers led by Mina Bissell … [Read more...] about Increased Glucose Metabolism is Oncogenic; Its Reversal May Be Therapeutic IB-2921
Native Cytokines for the Treatment of Advanced Breast Cancer and Other Tumors JIB-2718
APPLICATIONS OF TECHNOLOGY: Treatment of breast and other cancers ADVANTAGES: Targets cancer cells only; does not damage normal cells Enhanced efficacy in the most aggressive breast tumors No known side effects Potential expansion to other solid tumor types ABSTRACT: Mina Bissell and colleagues at Berkeley Lab have identified and isolated several … [Read more...] about Native Cytokines for the Treatment of Advanced Breast Cancer and Other Tumors JIB-2718
Acid-Degradeable and Bioerodible Materials JIB-2595
APPLICATIONS OF TECHNOLOGY: Drug delivery, including controlled-release formulations Vaccine and immunotherapy Gene therapy Chemotherapy Sutures, scaffolds, and implantable bulk materials Diagnosis and imaging ADVANTAGES: Site-specific delivery, accurate therapeutic targeting Payload release or degradation rate can be tuned easily—from minutes to hours to … [Read more...] about Acid-Degradeable and Bioerodible Materials JIB-2595
Detecting and Treating Breast Cancer Resistance to EGFR Inhibitors IB-2578
ABSTRACT: Mina Bissell and colleagues at Berkeley Lab have developed therapeutic compositions and methods related to inhibition of FAM83A as well as methods of diagnosing cancer resistance to EGFR inhibitors. For details, see the issued U. S. Patent #9,303,088, available at www.uspto.gov. FOR MORE … [Read more...] about Detecting and Treating Breast Cancer Resistance to EGFR Inhibitors IB-2578